He aha te tikanga o te "Maama"?
Karekau te kararehe e kawe i te huringa. E kore e whakawhanake i te mate a e kore e tukuna atu.
Autosomal Dominant Progressive Retinal Atrophy (DPRA) is a genetic eye disorder affecting dogs. DPRA leads to progressive vision loss and eventual blindness if left undetected and unmanaged. A DNA test for DPRA helps breeders identify carriers, reducing disease prevalence in future litters. Early genetic testing ensures healthier puppies and protects the breed's overall visual health. DPRA DNA testing is simple, accurate, and essential for responsible dog breeding practices. Regular screening empowers dog owners to make informed breeding decisions and protect canine vision. Invest in DPRA genetic testing today for healthier, happier dogs and enhanced breed integrity.
The autosomal dominant progressive retinal atrophy (dPRA) DNA test identifies a genetic mutation causing vision loss in dogs. dPRA is inherited as an autosomal dominant trait, meaning only one affected copy of the gene is sufficient for disease to manifest. Early genetic testing allows breeders and owners to detect carriers and affected individuals, guiding responsible breeding practices. Regular screening can help reduce the prevalence of dPRA, ensuring healthier generations. Ultimately, DNA testing helps maintain canine eye health and improves overall breed quality.
Kua whakauruhia tenei whakamatautau DNA mai i ta maatau kete Basic — he waahanga ano hoki o nga kete Basic, Standard, Advanced, Complete.
Tirohia nga Puka Whakamatau DNA →Autosomal Dominant Progressive Retinal Atrophy (dPRA) is a hereditary eye disorder characterized by a gradual degeneration of the retina, leading to progressive vision impairment and eventual blindness in affected dogs. Unlike recessive forms of PRA, this condition is inherited through an autosomal dominant genetic pattern, meaning only one copy of the faulty gene, inherited from either parent, is sufficient to cause the disease.
Dogs affected by dPRA typically exhibit initial symptoms such as night blindness, difficulty navigating in low-light conditions, and increased pupil dilation. Over time, as retinal degeneration progresses, daytime vision also deteriorates, ultimately resulting in complete blindness. The rate of progression and the age at which symptoms first appear can vary significantly among individual dogs.
dPRA follows a dominant inheritance pattern, meaning that a dog with only one affected allele from either parent will exhibit the disease. Consequently, each offspring of an affected dog has a 50% chance of inheriting the disorder. Due to this dominant mode of inheritance, the condition can rapidly spread within a breeding line if not properly monitored and managed.
The DNA test for dPRA identifies the presence or absence of the genetic mutation responsible for the disease. It is a reliable tool allowing breeders and veterinarians to detect affected or carrier animals before clinical signs appear. Early identification is crucial in making informed breeding decisions and helps prevent the propagation of the disorder in future generations.
DNA testing provides vital information to dog owners, breeders, and veterinarians to manage the condition effectively. By identifying affected individuals early, breeding programs can reduce or eliminate the occurrence of dPRA, enhancing breed health and improving the quality of life for dogs. Additionally, early detection allows dog owners to implement appropriate management strategies, such as regular veterinary monitoring, adjustments to home environments, and other supportive care to improve the affected dog's quality of life.
Autosomal Dominant Progressive Retinal Atrophy is a serious genetic condition that significantly impacts canine health and quality of life. DNA testing represents a valuable method for early detection, responsible breeding, and effective disease management. Through careful genetic screening and informed breeding decisions, it is possible to reduce the prevalence and impact of dPRA in canine populations.
Karekau te kararehe e kawe i te huringa. E kore e whakawhanake i te mate a e kore e tukuna atu.
Kao. He hauora te kararehe engari ka taea e ia te tuku i te huringa ki tona uri.
E rua nga kape whakarereke. Ko nga tohu haumanu kei te tumanakohia te mate. Kaua e whakatipuria.
Ko etahi o nga mate he hononga-a-ira, no reira ka rereke o raatau korero i runga i te ira kararehe.
This DNA test detects the mutation associated with Autosomal Dominant Progressive Retinal Atrophy (dPRA) in order to identify clear, carrier, or at-risk animals.
Ko te whakamatautau DNA ka awhina i nga kaiwhakawhanake ki te whakamahere i nga hononga haumaru ake me te whakaiti i te tupono ki te tuku i te huringa ki nga uri.
Ko te tikanga tuku iho mo tenei whakamatautau ko Autosomal Dominant.
This test analyses the mutation RHO c.11C>G.
Ehara i te mea. Ko te whakamaoritanga ka whakawhirinaki ki te tauira tuku iho me te momo momo ira ka puta.
Kijas James W, Cideciyan Artur V, Aleman Tomas S, Pianta Michael J, PearceKelling Susan E, Miller Brian J, Jacobson Samuel G, Aguirre Gustavo D, Acland Gregory M. Naturally occurring rhodopsin mutation in the dog causes retinal dysfunction and degeneration mimicking human dominant retinitis pigmentosa. Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6328-33. doi: 10.1073/pnas.082714499. Epub 2002 Apr 23.
To tūmataitinga, to whiringa
Ka whakamahi matou i nga pihikete whakahirahira hei whakahaere i te paetukutuku. Ko nga pihikete whiriwhiri (penei i nga kaiwhakarato ihirangi kua whakauruhia) kua monoa ma te taunoa ka whakahohea mena ka whakaae koe. Ka taea e koe te huri i to whiringa i nga wa katoa ma te whakamahi i te paatene "Pihikete".
E hiahiatia ana mo nga ahuatanga matua me te haumarutanga. Whakahohea i nga wa katoa.
Ka whakapai ake i nga ahuatanga penei i te penapena manakohanga, i nga taapiri kore-panui ranei.
Ka awhina tatou ki te mohio ki te whakamahinga o te waahi. Kua monoa e te taunoa.
Panuitanga / aroturuki puta noa i nga waahi (etahi riipene whakaata / mapi kua whakauruhia). Kua monoa e te taunoa.